GS

Gursimranpreet Singh Buttar

Active Director Director DIN 10672395
DIN 10672395 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Gursimranpreet Singh Buttar

Data last updated:

Gursimranpreet Singh Buttar is a Director at Bhagtabhai Pharmaceuticals Private Limited (since 2024) and Director at Pedanthealth Private Limited (since 2024). The companies operate in Pharma and Healthcare.

DIN 10672395
Primary Designation Director
Industry Pharma
First Appointment 22 Jun 2024
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Oct 20242024Active
Pedanthealth Private Limited U85200DL2016PTC309681
Director22 Jun 20242016Active

Board colleagues of Gursimranpreet Singh Buttar

Directorship timeline

Open interactive timeline →
Bhagtabhai Pharmaceuticals Private Limited
Pedanthealth Private Limited
Premium access

Shareholding and investment profile for Gursimranpreet Singh Buttar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gursimranpreet Singh Buttar

Gursimranpreet Singh Buttar currently holds 2 directorships: Bhagtabhai Pharmaceuticals Private Limited (Director, since 22 Oct 2024); Pedanthealth Private Limited (Director, since 22 Jun 2024).

Gursimranpreet Singh Buttar was first appointed on 22 Jun 2024 as Director at Pedanthealth Private Limited.

The current boards of Gursimranpreet Singh Buttar's companies include Angat Mahal (Bhagtabhai Pharmaceuticals Private Limited), Harpran Singh (Pedanthealth Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available